Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: Reliable markers for individual strain identification

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 240-244

  Berger, Christoph ^b   Van Baarle, Debbie ^b   Kersten, Marie José ^b   Klein, Michèl R ^b   Al Homsi, A Samer ^b   Dunn, Brenda ^b   McQuain, Cathy ^b   Van Oers, Rien ^b   Knecht, Hans ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; MALE; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN VARIANT; SEROCONVERSION; STRAIN DIFFERENCE; VIRUS CHARACTERIZATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENETIC MARKERS; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LONGITUDINAL STUDIES; LYMPHOMA, AIDS-RELATED; MALE; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; VARIATION (GENETICS); VIRAL MATRIX PROTEINS;

EID: 0013533898     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314547     Document Type: Article

References (15)

1. Rickinson AB, Kieff E. Epstein-Barr virus. Fields BN, Knipe DM, Howley PM, et al., eds. Fields virology. Philadelphia: Lippincott-Raven, 1996: 2397-446.
2. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 1998;91:1373-81.
3. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
4. Knecht H, Berger C, Al-Homsi AS, McQuain C, Brousset P. Epstein-Barr virus oncogenesis. Crit Rev Oncol Hematol 1997;26:117-35.
5. Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-409.
6. Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996;12:2129-35.
7. Berger C, McQuain C, Sullivan J, Nadal D. Quesenberry PJ, Knecht H. The 30-bp deletion variant of Epstein-Barr virus encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis 1997;176:1370-3.
8. Kersten MJ, Klein MR, Holwerda AM, et al. Epstein-Barr virus specific cytotoxic T cell responses in HIV-1 infection. J Clin Invest 1997;99: 1525-33.
9. Klein MR, van Baalen C, Holwerda AM, et al. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-72.
10. Knecht H, Bachmann E, Joske DJL, et al. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993;7:580-5.
11. Miller CL, Burkhardt AL, Lee JH, et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995;2:155-66.
12. Rothenberger S, Bachmann E, Knecht H. Molecular and functional analysis of the Epstein-Barr virus LMP1 oncogene promoter in lymphoproliferative diseases. Exp Hematol 1997;25:1326-32.
13. Yao QY, Tierney RJ, Croom-Carter D, et al. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 1996;70:4884-94.
14. Walling DM, Perkins AG, Webster-Cyriaque J, et al. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol 1994;68:7918-26.
15. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.